BriaCell Therapeutics Corp.
BCTXW · NASDAQ
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4,273 | $169,486 | $1,368,283 | $1,298,404 |
| - Cash | $10,494 | $862 | $21,251 | $41,042 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$6,220 | $168,624 | $1,347,032 | $1,257,363 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$148 | -$114 | -$20 | -$19 |
| % Margin | – | – | – | – |
| EBITDA | -$36,635 | -$46 | -$27,227 | -$34,047 |
| % Margin | – | – | – | – |
| Net Income | -$36,495 | -$7 | -$20,302 | -$11,581 |
| % Margin | – | – | – | – |
| EPS Diluted | -86.25 | -4.28 | -19.79 | -25.7 |
| % Growth | -1,915.2% | 78.4% | 23% | – |
| Operating Cash Flow | -$28,171 | -$24,126 | -$23,745 | -$12,484 |
| Capital Expenditures | $0 | -$457 | $0 | $0 |
| Free Cash Flow | -$28,171 | -$24,583 | -$23,745 | -$12,484 |